Surgalign Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2023 to a ratio of 4.59, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the first quarter 2023. Average receivable collection period, for the Surgalign Holdings Inc in Mar 31 2023 quarter, has decreased to 80 days, compared to 84 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 90 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1119, from overall ranking in the fourth quarter 2022 at 3030.

What is Receivable Turnover Ratio?
What is Surgalign Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SRGA Receivables Turnover Ratio	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	-38.53 %	-16.36 %	-8.3 %	-32.79 %	-30.24 %
Y / Y Revenue Change	-18.72 %	-5.76 %	-1.79 %	-16.96 %	-11.53 %
Receivable Turnover Ratio (TTM)	4.59	4.32	4.21	4.14	3.87
SRGA's Total Ranking	# 1119	# 3030	# 1086	# 3030	# 1333
Accounts Receivable average collection period days	80	85	87	88	94
Seq. Receivable Change	-21.69 %	-15.21 %	-7.63 %	0.22 %	6.57 %
Seq. Revenue Change	-18.59 %	1.96 %	-2.16 %	0.09 %	-5.61 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 42
Healthcare Sector	# 91
Overall Market	# 1119

Receivable Turnover Ratio Statistics
High	Average	Low
0.94	0.56	0.1
(Mar 31 2023)		(Sep 30 2021)

SRGA Company Profile • Back to SRGA Efficiency Comparisons • Compare SRGA Receivables Turnover Ratio to its Competitors

Financial Statements
Surgalign Holdings Inc 's Accounts Receivable	$ 13 Millions	Visit SRGA's Balance sheet
Surgalign Holdings Inc 's Sales TTM	$ 78 Millions	Visit SRGA's Income Statement
Sources of SRGA's Revenues		Visit SRGA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SRGA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SRGA's Growth Rates	SRGA's Roa	SRGA's Inventory Turnover Ratio	SRGA's Dividend Comparisons
SRGA's Profitability Ratios	SRGA's Roi	SRGA's Asset Turnover Ratio	SRGA's Dividend Growth
SRGA's Valuation Ratios	SRGA's Roe	SRGA's Financial Strength Ratios	SRGA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Arbutus Biopharma Corp	16.93	$ 33.125 Millions	$ 1.957 Millions
Innovage Holding Corp	16.89	$ 684.074 Millions	$ 40.506 Millions
Qhslab Inc	16.88	$ 1.241 Millions	$ 0.074 Millions
Thorne Healthtech Inc	16.72	$ 239.301 Millions	$ 14.315 Millions
Akili Inc	16.67	$ 0.500 Millions	$ 0.030 Millions
Tango Therapeutics Inc	16.58	$ 24.868 Millions	$ 1.500 Millions
Emmaus Life Sciences Inc	16.52	$ 21.909 Millions	$ 1.326 Millions
Nutriband Inc	16.47	$ 2.079 Millions	$ 0.126 Millions
Petvivo Holdings Inc	16.44	$ 0.917 Millions	$ 0.056 Millions
Catalyst Pharmaceuticals Inc	16.35	$ 256.480 Millions	$ 15.691 Millions
Zymeworks Inc	16.04	$ 446.144 Millions	$ 27.810 Millions
Clearside Biomedical Inc	16.00	$ 0.984 Millions	$ 0.062 Millions
Chemed Corporation	15.70	$ 2,164.571 Millions	$ 137.860 Millions
Neptune Wellness Solutions Inc	15.37	$ 52.615 Millions	$ 3.423 Millions
Arrowhead Pharmaceuticals Inc	15.05	$ 272.800 Millions	$ 18.123 Millions
Patterson Companies Inc	15.01	$ 6,471.471 Millions	$ 431.274 Millions
Rvl Pharmaceuticals Plc	14.81	$ 37.109 Millions	$ 2.506 Millions
Zomedica Corp	14.79	$ 20.661 Millions	$ 1.397 Millions
Editas Medicine Inc	14.66	$ 22.792 Millions	$ 1.555 Millions
Wearable Health Solutions, Inc.	14.38	$ 0.834 Millions	$ 0.058 Millions
Revance Therapeutics Inc	14.23	$ 156.635 Millions	$ 11.009 Millions
23andme Holding Co	14.18	$ 299.489 Millions	$ 21.127 Millions
Eton Pharmaceuticals Inc	13.82	$ 24.379 Millions	$ 1.765 Millions
Vystar Corporation	13.79	$ 5.297 Millions	$ 0.384 Millions
Intellia Therapeutics Inc	13.75	$ 53.475 Millions	$ 3.888 Millions
Corcept Therapeutics Inc	13.66	$ 413.824 Millions	$ 30.298 Millions
Strata Critical Medical Inc	13.65	$ 164.761 Millions	$ 12.071 Millions
Lifeloc Technologies Inc	13.23	$ 8.486 Millions	$ 0.641 Millions
Invo Fertility Inc	13.23	$ 1.008 Millions	$ 0.076 Millions
Cano Health Inc	13.20	$ 2,901.488 Millions	$ 219.766 Millions

Date modified: 2026-08-29T17:40:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.